Transferring fixed assets of the Kobe Research Institute and planning to record a gain on sale of fixed assets as a special gain. The transferee is not disclosed. Schedule: Board resolution date 2026-11-04, contract signing date 2026-11-09, handover date 2026-12-01. The special gain is expected to be recorded in Q3 of the fiscal year ending March 2027, while the impact on earnings forecasts remains under review.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2342","jir_company_name":"Transgenic Group Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-11-04","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/2342-20261104-01.pdf","jir_short_summary":"Transferring fixed assets of the Kobe Research Institute and planning to record a gain on sale of fixed assets as a special gain. The transferee is not disclosed. Schedule: Board resolution date 2026-11-04, contract signing date 2026-11-09, handover date 2026-12-01. The special gain is expected to be recorded in Q3 of the fiscal year ending March 2027, while the impact on earnings forecasts remains under review.","jir_summary":"### Summary of the News\nTransgenic Group Inc. will transfer fixed assets of the Kobe Research Institute and plans to record the resulting gain on sale as a special gain. This transaction is part of business function reallocation associated with the closure of the Kobe Research Institute and aims to improve capital efficiency. The transfer price was assessed for reasonableness based on a third-party appraisal. Schedule: Board resolution date 2026-11-04, contract signing date 2026-11-09, handover date 2026-12-01.\n\n### Outlook and Impact\nThe special gain is expected to be recorded in the consolidated accounting period for Q3 of the fiscal year ending March 2027. However, this special gain has not been incorporated into the full-year consolidated earnings forecast announced in May 2026, and the determination of its impact is under review. Any matters that should be disclosed in the future will be announced promptly.","jir_financial_highlights":"Transfer price: 1,266 million yen (Unknown)\nBook value: 912 million yen (as of September 30, 2026) (Unknown)\nGain on transfer: 310 million yen (Unknown)","jir_category":"","jir_hashtags":"#ConsideringShareBuyback, #KobeResearchInstitute, #SpecialGain","jir_key_figures":"Transfer price: 1,266 million yen (transferee not disclosed)\nBook value: 912 million yen (as of September 30, 2026)\nGain on transfer: 310 million yen","jir_meta_title":"Transgenic Group Inc. \u2014 Notice of Fixed Asset Transfer and Recording of Special Gain | November 2026","jir_meta_description":"Transgenic Group Inc. will transfer fixed assets of the Kobe Research Institute and record the gain on sale as a special gain. Schedule: board resolution 2026-11-04, contract 2026-11-09, handover 2026-12-01. The impact on future earnings is under review.","jir_og_title":"Transgenic Group Inc. \u2014 Notice of Fixed Asset Transfer and Recording of Special Gain","jir_og_description":"Announcement of the transfer of fixed assets of the Kobe Research Institute and recording of a special gain. Transfer price 1,266 million yen; gain on transfer 310 million yen. The impact on future earnings is undetermined.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60051,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-141097","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n